The predictive and prognostic value of serum CA125 kinetics and CA125 nadir during paclitaxel/platinum based chemotherapy (QT) in patients with advanced ovarian carcinoma (OC)

被引：0
|
作者：
Tibau, A. [1 ]
Ojeda, M. B. [1 ]
Nadal, R. M. [2 ]
Gallardo, A. [1 ]
Perez Altozano, J. [1 ]
Sala, N. [1 ]
Mazarico, J. M. [1 ]
Boguna, I. [1 ]
Artigas, V. [1 ]
Barnadas, A. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Hosp del Mar, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71548-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [1] The predictive and prognostic value of serum CA 125 kinetics and CA 125 nadir during paclitaxel/platinum based chemotherapy in patients with advanced ovarian carcinoma
    Tibau, A.
    Ojeda, B.
    Nadal, R.
    Altozano, J. Perez
    Boguna, I.
    Artigas, V.
    Gallardo, A.
    Perez, C.
    Lopez, J.
    Barnadas, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] The prognostic significance of the CA125 nadir in patients that achieve a CA125 response.
    Crawford, SM
    Paul, J
    Reed, NS
    Hay, A
    Carty, K
    Vasey, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 449S - 449S
  • [3] Prognostic value of serial CA125 measurements during chemotherapy for patients with advanced ovarian cancer
    Koper, NP
    Massuger, LFAG
    Thomas, CMG
    Kiemeney, LALM
    Schijf, CPT
    Beex, LVAM
    Verbeek, ALM
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (02) : 127 - 133
  • [4] The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma
    Gadducci, A
    Cosio, S
    Fanucchi, A
    Negri, S
    Cristofani, R
    Genazzani, AR
    GYNECOLOGIC ONCOLOGY, 2004, 93 (01) : 131 - 136
  • [5] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Baron, AT
    Maihle, N
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 288 - 289
  • [6] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Andre T Baron
    Nita Maihle
    Nature Clinical Practice Oncology, 2005, 2 : 288 - 289
  • [7] Prechemotherapy serum CA125 level, CA125 kinetics and its half-life as prognostic factors in advanced ovarian cancer.
    Colakovic, S
    Lukic, V
    Mitrovic, L
    Jelic, S
    Susnjar, S
    Marinkovic, J
    ANNALS OF ONCOLOGY, 2000, 11 : 82 - 83
  • [8] Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer
    Colakovic, S
    Lukiç, V
    Mitroviç, L
    Jeliç, S
    Susnjar, S
    Marinkoviç, J
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (02): : 147 - 152
  • [9] Prognostic value of CA125 in advanced heart failure patients
    Monteiro, Silvia
    Franco, Fatima
    Costa, Susana
    Monteiro, Pedro
    Vieira, Henrique
    Coelho, Lourenco
    Oliveira, Luis
    Providencia, Luis A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 (01) : 115 - 118
  • [10] THE PROGNOSTIC VALUE OF EARLY CA125 SERUM ASSAY IN EPITHELIAL OVARIAN-CARCINOMA
    FISKEN, J
    LEONARD, RCF
    STEWART, M
    BEATTIE, GJ
    STURGEON, C
    ASPINALL, L
    ROULSTON, JE
    BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 140 - 145
12345